Details of the Drug

General Information of Drug (ID: DMWO3KW)

Drug Name

mRNA-5671

Indication

Disease Entry	ICD 11	Status	REF
Non-small-cell lung cancer	2C25.Y	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Vaccine

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03948763) A Study of mRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001). U.S. National Institutes of Health.